D.A. Davidson & Co. Sorrento Therapeutics, Inc. Transaction History

D.A. Davidson & Co.

  • $12 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 07, 2021
SELL
$7.03 - $16.51 $112,480 - $264,160
-16,000 Closed
0 $0
Q3 2020

Nov 02, 2020
BUY
$6.17 - $18.82 $33,935 - $103,510
5,500 Added 52.38%
16,000 $178,000
Q2 2020

Aug 10, 2020
BUY
$1.73 - $6.76 $18,165 - $70,980
10,500 New
10,500 $66,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track D.A. Davidson & Co. Portfolio

Follow D.A. Davidson & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email